Covalent Group, Inc.

Clinical trials company announces new business contracts with an aggregate value of $1M

Published in Pharma Investments, Ventures and Law Weekly, February 26th, 2006

Covalent Group, Inc., (CVGR), a company engaged in the design, development, and management of complex clinical trials and patient registries for pharmaceutical and biotechnology companies, announced that it has signed multiple new contracts with an aggregate value of approximately $1.0 million.

These contracts are for consulting services as well as for changes-of-scope for existing business. Services to be provided include protocol design and strategic consulting, clinical operations, and medical writing. The therapeutic areas covered are cardiovascular, nephrology, vaccines, and ophthalmology.

Revenue for these contracts will be recognized on a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly

Source: Pharma Investments, Ventures and Law Weekly (2006-02-26)

More Articles from Pharma Investments, Ventures and Law Weekly

BioSphere Medical, Inc.
Uterine fibroid treatment developer reports 20% revenue growth
Biomira, Inc.
Oncology company arranges $16.1M financing
Celgene Corp.
REVLIMID maker reports record operating performance for 2005
Covance, Inc.
Covance announces record results, raises 2006 EPS target
Cubist Pharmaceuticals, Inc.
Cubicin maker reports Q4 full-year 2005 results; full-year loss per share totals 60 cents
Diamyd Medical AB
Diabetes therapy developer reports loss per share of SEK0.9
More from this issue of Pharma Investments, Ventures and Law Weekly

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry